Coexpression cluster:C92

Full id: C92_CD14CD16_CD14_Eosinophils_Basophils_Neutrophils_Macrophage_Whole

Phase1 CAGE Peaks

Hg19::chr10:101379080..101379085,+	p@chr10:101379080..101379085 +
Hg19::chr10:104556220..104556247,-	p@chr10:104556220..104556247 -
Hg19::chr10:104556407..104556425,+	p@chr10:104556407..104556425 +
Hg19::chr10:114594528..114594539,-	p@chr10:114594528..114594539 -
Hg19::chr10:114885446..114885465,+	p@chr10:114885446..114885465 +
Hg19::chr10:115070193..115070207,-	p@chr10:115070193..115070207 -
Hg19::chr10:115080077..115080087,-	p@chr10:115080077..115080087 -
Hg19::chr10:43609342..43609351,+	p@chr10:43609342..43609351 +
Hg19::chr10:73473819..73473836,+	p@chr10:73473819..73473836 +
Hg19::chr10:73534273..73534295,-	p@chr10:73534273..73534295 -
Hg19::chr10:73588893..73588912,-	p@chr10:73588893..73588912 -
Hg19::chr10:81742364..81742375,-	p2@SFTPD
Hg19::chr11:117056662..117056716,+	p7@SIDT2
Hg19::chr11:117056719..117056726,+	p28@SIDT2
Hg19::chr11:117056730..117056740,+	p15@SIDT2
Hg19::chr11:117056889..117056905,+	p21@SIDT2
Hg19::chr11:122614916..122614928,+	p@chr11:122614916..122614928 +
Hg19::chr11:2323009..2323021,-	p7@C11orf21
Hg19::chr11:2905326..2905374,-	p@chr11:2905326..2905374 -
Hg19::chr11:504207..504213,+	p@chr11:504207..504213 +
Hg19::chr11:60146107..60146118,+	p6@MS4A7
Hg19::chr11:67051186..67051245,+	p3@ADRBK1
Hg19::chr11:67415202..67415246,-	p5@ACY3
Hg19::chr12:117504933..117504940,-	p@chr12:117504933..117504940 -
Hg19::chr12:121976319..121976333,-	p@chr12:121976319..121976333 -
Hg19::chr12:123752764..123752835,-	p7@CDK2AP1
Hg19::chr12:123752843..123752879,-	p10@CDK2AP1
Hg19::chr12:12871327..12871345,+	p@chr12:12871327..12871345 +
Hg19::chr12:29727591..29727616,-	p@chr12:29727591..29727616 -
Hg19::chr14:101150099..101150117,+	p@chr14:101150099..101150117 +
Hg19::chr14:101150133..101150145,+	p@chr14:101150133..101150145 +
Hg19::chr14:105954292..105954314,+	p7@CRIP1
Hg19::chr14:23282256..23282282,-	p17@SLC7A7
Hg19::chr14:52782082..52782100,-	p@chr14:52782082..52782100 -
Hg19::chr14:52782111..52782133,-	p@chr14:52782111..52782133 -
Hg19::chr14:92927429..92927462,+	p@chr14:92927429..92927462 +
Hg19::chr14:92927464..92927488,+	p@chr14:92927464..92927488 +
Hg19::chr15:22538560..22538601,-	p@chr15:22538560..22538601 -
Hg19::chr15:22550722..22550726,+	p@chr15:22550722..22550726 +
Hg19::chr15:38296918..38296944,+	p1@ENST00000557883
Hg19::chr15:75080883..75080890,+	p14@CSK
Hg19::chr15:75422284..75422300,-	p@chr15:75422284..75422300 -
Hg19::chr15:86098640..86098665,+	p13@AKAP13
Hg19::chr16:1538765..1538796,-	p1@PTX4
Hg19::chr16:1538881..1538887,+	p@chr16:1538881..1538887 +
Hg19::chr16:17460967..17460974,-	p@chr16:17460967..17460974 -
Hg19::chr16:19179856..19179908,+	p2@SYT17
Hg19::chr16:30484090..30484101,+	p4@ITGAL
Hg19::chr16:4563100..4563144,-	p12@C16orf5
Hg19::chr16:50313353..50313370,+	p@chr16:50313353..50313370 +
Hg19::chr16:67429107..67429142,-	p@chr16:67429107..67429142 -
Hg19::chr16:67429148..67429159,-	p@chr16:67429148..67429159 -
Hg19::chr16:67429168..67429188,-	p@chr16:67429168..67429188 -
Hg19::chr16:68032947..68032953,+	p@chr16:68032947..68032953 +
Hg19::chr16:85096580..85096602,+	p3@KIAA0513
Hg19::chr17:40351201..40351230,+	p@chr17:40351201..40351230 +
Hg19::chr17:47287786..47287800,-	p@chr17:47287786..47287800 -
Hg19::chr17:47288020..47288029,+	p3@ABI3
Hg19::chr17:48870630..48870661,+	p@chr17:48870630..48870661 +
Hg19::chr17:531650..531657,-	p@chr17:531650..531657 -
Hg19::chr17:531669..531692,-	p@chr17:531669..531692 -
Hg19::chr17:531709..531723,-	p@chr17:531709..531723 -
Hg19::chr17:61776536..61776553,-	p@chr17:61776536..61776553 -
Hg19::chr17:61776579..61776588,-	p@chr17:61776579..61776588 -
Hg19::chr17:61777090..61777112,-	p7@LIMD2
Hg19::chr17:72439704..72439736,+	p8@GPRC5C
Hg19::chr17:72563495..72563524,-	p3@ENST00000425002
Hg19::chr17:72563552..72563583,-	p1@ENST00000425002
Hg19::chr17:72563586..72563601,-	p5@ENST00000425002
Hg19::chr17:72563622..72563633,-	p4@ENST00000425002
Hg19::chr17:72563639..72563654,-	p2@ENST00000425002
Hg19::chr17:72595953..72595966,+	p@chr17:72595953..72595966 +
Hg19::chr17:72595971..72595990,+	p@chr17:72595971..72595990 +
Hg19::chr17:72595995..72596020,+	p@chr17:72595995..72596020 +
Hg19::chr17:75430998..75431040,+	p@chr17:75430998..75431040 +
Hg19::chr17:75440858..75440875,+	p1@ENST00000450721
Hg19::chr17:76123130..76123168,-	p13@TMC6
Hg19::chr17:80064388..80064407,-	p@chr17:80064388..80064407 -
Hg19::chr17:80843910..80843933,+	p@chr17:80843910..80843933 +
Hg19::chr17:81103313..81103332,-	p@chr17:81103313..81103332 -
Hg19::chr18:13569295..13569309,+	p@chr18:13569295..13569309 +
Hg19::chr19:10959147..10959176,+	p2@C19orf38
Hg19::chr19:14546214..14546245,+	p@chr19:14546214..14546245 +
Hg19::chr19:14887911..14887932,-	p3@EMR2
Hg19::chr19:18283959..18283993,+	p@chr19:18283959..18283993 +
Hg19::chr19:18507990..18508011,-	p3@LRRC25
Hg19::chr19:18529581..18529594,+	p@chr19:18529581..18529594 +
Hg19::chr19:18529684..18529699,+	p6@SSBP4
Hg19::chr19:36398384..36398407,+	p@chr19:36398384..36398407 +
Hg19::chr19:47614483..47614496,-	p@chr19:47614483..47614496 -
Hg19::chr19:47834063..47834081,+	p@chr19:47834063..47834081 +
Hg19::chr19:50283657..50283673,+	p@chr19:50283657..50283673 +
Hg19::chr19:50283684..50283702,+	p@chr19:50283684..50283702 +
Hg19::chr19:50284801..50284815,+	p@chr19:50284801..50284815 +
Hg19::chr19:50284821..50284856,+	p@chr19:50284821..50284856 +
Hg19::chr19:50285177..50285181,+	p@chr19:50285177..50285181 +
Hg19::chr19:54710115..54710150,+	p@chr19:54710115..54710150 +
Hg19::chr19:55105085..55105136,+	p1@LILRA1
Hg19::chr19:55128414..55128437,+	p4@LILRB1
Hg19::chr19:55207635..55207643,+	p@chr19:55207635..55207643 +
Hg19::chr1:112016594..112016617,+	p1@C1orf162
Hg19::chr1:12185656..12185684,+	p10@TNFRSF8
Hg19::chr1:12185997..12186018,+	p5@TNFRSF8
Hg19::chr1:161519583..161519620,-	p1@FCGR3A
Hg19::chr1:161519682..161519691,-	p7@FCGR3A
Hg19::chr1:161600900..161600923,-	p3@FCGR3B p4@FCGR3A
Hg19::chr1:181104200..181104242,+	p@chr1:181104200..181104242 +
Hg19::chr1:192128293..192128310,+	p@chr1:192128293..192128310 +
Hg19::chr1:192128363..192128374,+	p@chr1:192128363..192128374 +
Hg19::chr1:26186028..26186052,+	p1@ENST00000455431
Hg19::chr1:26186058..26186081,+	p2@ENST00000455431
Hg19::chr1:26634917..26634921,+	p@chr1:26634917..26634921 +
Hg19::chr20:30793004..30793008,-	p@chr20:30793004..30793008 -
Hg19::chr20:62708461..62708503,-	p7@RGS19
Hg19::chr20:62711482..62711505,+	p4@OPRL1
Hg19::chr20:825275..825293,+	p3@FAM110A
Hg19::chr20:825297..825306,+	p7@FAM110A
Hg19::chr20:825327..825342,+	p4@FAM110A
Hg19::chr20:827656..827661,-	p@chr20:827656..827661 -
Hg19::chr21:44765881..44765892,-	p@chr21:44765881..44765892 -
Hg19::chr21:45232138..45232176,-	p1@LOC284837
Hg19::chr21:45232423..45232443,-	p2@LOC284837
Hg19::chr22:30714833..30714846,-	p4@TBC1D10A
Hg19::chr2:219125714..219125758,+	p1@GPBAR1
Hg19::chr2:219125814..219125822,+	p3@GPBAR1
Hg19::chr2:219125838..219125849,+	p2@GPBAR1
Hg19::chr2:238600416..238600432,-	p@chr2:238600416..238600432 -
Hg19::chr2:241906812..241906837,-	p2@LOC200772
Hg19::chr2:241906841..241906868,-	p1@LOC200772
Hg19::chr2:241906877..241906887,-	p3@LOC200772
Hg19::chr2:29337060..29337092,+	p3@CLIP4
Hg19::chr2:29337097..29337111,+	p10@CLIP4
Hg19::chr2:29337114..29337117,+	p21@CLIP4
Hg19::chr2:71047727..71047733,-	p1@CLEC4F
Hg19::chr3:101597149..101597179,+	p@chr3:101597149..101597179 +
Hg19::chr3:132036352..132036365,+	p6@ACPP
Hg19::chr3:132036369..132036382,+	p5@ACPP
Hg19::chr3:196417056..196417097,+	p@chr3:196417056..196417097 +
Hg19::chr3:39321512..39321533,-	p1@CX3CR1
Hg19::chr3:46968769..46968781,-	p@chr3:46968769..46968781 -
Hg19::chr3:50658125..50658131,+	p@chr3:50658125..50658131 +
Hg19::chr3:50658577..50658589,+	p@chr3:50658577..50658589 +
Hg19::chr4:1582183..1582209,-	p1@ENST00000466692
Hg19::chr4:2787568..2787572,+	p@chr4:2787568..2787572 +
Hg19::chr4:2794535..2794549,-	p@chr4:2794535..2794549 -
Hg19::chr4:3374958..3374970,+	p@chr4:3374958..3374970 +
Hg19::chr4:76861392..76861418,-	p3@NAAA
Hg19::chr4:76862117..76862186,-	p1@NAAA
Hg19::chr5:114887365..114887382,+	p@chr5:114887365..114887382 +
Hg19::chr5:14331744..14331753,+	p@chr5:14331744..14331753 +
Hg19::chr5:14331797..14331811,+	p@chr5:14331797..14331811 +
Hg19::chr5:169064317..169064332,+	p2@DOCK2
Hg19::chr5:171601123..171601129,+	p@chr5:171601123..171601129 +
Hg19::chr5:172232848..172232850,-	p@chr5:172232848..172232850 -
Hg19::chr5:180237681..180237700,+	p2@BC017750
Hg19::chr5:56112783..56112806,+	p@chr5:56112783..56112806 +
Hg19::chr5:76145904..76145918,+	p3@S100Z
Hg19::chr5:76145920..76145948,+	p2@S100Z
Hg19::chr6:116782527..116782550,+	p4@FAM26F
Hg19::chr6:144952186..144952227,+	p@chr6:144952186..144952227 +
Hg19::chr6:144980477..144980514,+	p4@UTRN
Hg19::chr6:144980558..144980569,+	p30@UTRN
Hg19::chr6:144980756..144980774,+	p22@UTRN
Hg19::chr6:144980777..144980799,+	p13@UTRN
Hg19::chr6:144980861..144980870,+	p38@UTRN
Hg19::chr6:144980916..144980928,+	p23@UTRN
Hg19::chr6:144980954..144980988,+	p11@UTRN
Hg19::chr6:144981000..144981016,+	p14@UTRN
Hg19::chr6:31553978..31554060,+	p1@LST1
Hg19::chr6:31554755..31554764,+	p11@LST1
Hg19::chr6:31554766..31554777,+	p8@LST1
Hg19::chr6:31554826..31554845,+	p4@LST1
Hg19::chr6:31554962..31554987,+	p5@LST1
Hg19::chr6:31554992..31555041,+	p2@LST1
Hg19::chr6:31555045..31555057,+	p9@LST1
Hg19::chr6:31582990..31583096,+	p1@AIF1
Hg19::chr6:31584663..31584673,-	p@chr6:31584663..31584673 -
Hg19::chr7:101923300..101923343,+	p@chr7:101923300..101923343 +
Hg19::chr7:155055063..155055078,+	p@chr7:155055063..155055078 +
Hg19::chr7:20581331..20581339,-	p@chr7:20581331..20581339 -
Hg19::chr7:20581377..20581387,-	p@chr7:20581377..20581387 -
Hg19::chr7:2673037..2673047,-	p@chr7:2673037..2673047 -
Hg19::chr7:2673206..2673216,+	p@chr7:2673206..2673216 +
Hg19::chr7:2673688..2673709,-	p@chr7:2673688..2673709 -
Hg19::chr7:5596053..5596074,-	p@chr7:5596053..5596074 -
Hg19::chr7:77429034..77429040,-	p@chr7:77429034..77429040 -
Hg19::chr8:142384243..142384251,+	p@chr8:142384243..142384251 +
Hg19::chr8:142384271..142384329,+	p@chr8:142384271..142384329 +
Hg19::chr8:143833918..143833960,-	p1@LYPD2
Hg19::chr8:143833961..143833974,-	p2@LYPD2
Hg19::chr8:144480343..144480350,-	p@chr8:144480343..144480350 -
Hg19::chr8:37439077..37439090,+	p@chr8:37439077..37439090 +
Hg19::chr8:38758006..38758019,+	p@chr8:38758006..38758019 +
Hg19::chr8:52811117..52811133,+	p@chr8:52811117..52811133 +
Hg19::chr9:130540914..130540932,-	p5@SH2D3C
Hg19::chr9:136709727..136709738,+	p@chr9:136709727..136709738 +
Hg19::chr9:137267629..137267639,-	p@chr9:137267629..137267639 -
Hg19::chr9:137267647..137267658,-	p@chr9:137267647..137267658 -
Hg19::chr9:138967894..138967906,-	p@chr9:138967894..138967906 -
Hg19::chr9:140348244..140348308,-	p@chr9:140348244..140348308 -
Hg19::chrX:70712265..70712303,+	p4@TAF1
Hg19::chrY:2870975..2870988,+	p1@LINC00278

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

GO ID	GO name	FDR corrected p-value
GO:0016020	membrane	9.32023741352661e-06
GO:0004871	signal transducer activity	4.97454272835934e-05
GO:0060089	molecular transducer activity	4.97454272835934e-05
GO:0044425	membrane part	0.000885377741452317
GO:0008285	negative regulation of cell proliferation	0.0010982489843916
GO:0019864	IgG binding	0.00389780543213328
GO:0050672	negative regulation of lymphocyte proliferation	0.00492500838025483
GO:0032945	negative regulation of mononuclear cell proliferation	0.00492500838025483
GO:0048523	negative regulation of cellular process	0.00492500838025483
GO:0004872	receptor activity	0.00492500838025483
GO:0044464	cell part	0.00492500838025483
GO:0048519	negative regulation of biological process	0.00520183320258003
GO:0019865	immunoglobulin binding	0.00688185411257371
GO:0016021	integral to membrane	0.00688185411257371
GO:0031224	intrinsic to membrane	0.00688185411257371
GO:0005886	plasma membrane	0.00688185411257371
GO:0051250	negative regulation of lymphocyte activation	0.00832577728169739
GO:0032403	protein complex binding	0.00879372966006079
GO:0042127	regulation of cell proliferation	0.00921920829385283
GO:0008283	cell proliferation	0.00968728738051494
GO:0030595	leukocyte chemotaxis	0.00993913319223597
GO:0050900	leukocyte migration	0.0173228094301686
GO:0042330	taxis	0.0181469423724365
GO:0006935	chemotaxis	0.0181469423724365
GO:0007166	cell surface receptor linked signal transduction	0.0181469423724365
GO:0006952	defense response	0.0181469423724365
GO:0007165	signal transduction	0.018334818823925
GO:0045554	regulation of TRAIL biosynthetic process	0.0188999696750325
GO:0043129	surfactant homeostasis	0.0188999696750325
GO:0045553	TRAIL biosynthetic process	0.0188999696750325
GO:0048875	chemical homeostasis within a tissue	0.0188999696750325
GO:0032639	TRAIL production	0.0188999696750325
GO:0045556	positive regulation of TRAIL biosynthetic process	0.0188999696750325
GO:0009605	response to external stimulus	0.0188999696750325
GO:0005737	cytoplasm	0.0188999696750325
GO:0032944	regulation of mononuclear cell proliferation	0.0188999696750325
GO:0050670	regulation of lymphocyte proliferation	0.0188999696750325
GO:0006928	cell motility	0.0198542754536055
GO:0051674	localization of cell	0.0198542754536055
GO:0007626	locomotory behavior	0.0214749844586034
GO:0002376	immune system process	0.0236206013010033
GO:0030695	GTPase regulator activity	0.0249523236786799
GO:0032943	mononuclear cell proliferation	0.0252075945113539
GO:0046651	lymphocyte proliferation	0.0252075945113539
GO:0044459	plasma membrane part	0.0260685840256939
GO:0005515	protein binding	0.0276131105418551
GO:0019807	aspartoacylase activity	0.0276131105418551
GO:0047696	beta-adrenergic receptor kinase activity	0.0276131105418551
GO:0042035	regulation of cytokine biosynthetic process	0.0289078836085141
GO:0007154	cell communication	0.0299010405478368
GO:0016477	cell migration	0.0331147653005901
GO:0042089	cytokine biosynthetic process	0.0331147653005901
GO:0042107	cytokine metabolic process	0.0331147653005901
GO:0033209	tumor necrosis factor-mediated signaling pathway	0.0331147653005901
GO:0048286	alveolus development	0.0331147653005901
GO:0022401	adaptation of signaling pathway	0.0331147653005901
GO:0008157	protein phosphatase 1 binding	0.0331147653005901
GO:0002029	desensitization of G-protein coupled receptor protein signaling pathway	0.0331147653005901
GO:0045085	negative regulation of interleukin-2 biosynthetic process	0.0331147653005901
GO:0042608	T cell receptor binding	0.0331147653005901
GO:0006955	immune response	0.0344981384493859
GO:0051249	regulation of lymphocyte activation	0.0363072331852681
GO:0050865	regulation of cell activation	0.0389339002729788
GO:0045744	negative regulation of G-protein coupled receptor protein signaling pathway	0.0389339002729788
GO:0048246	macrophage chemotaxis	0.0389339002729788
GO:0048247	lymphocyte chemotaxis	0.0389339002729788
GO:0015051	X-opioid receptor activity	0.0389339002729788
GO:0004046	aminoacylase activity	0.0389339002729788
GO:0007186	G-protein coupled receptor protein signaling pathway	0.039985979963799
GO:0051329	interphase of mitotic cell cycle	0.039985979963799
GO:0051239	regulation of multicellular organismal process	0.0400152244196185
GO:0000267	cell fraction	0.0427906431484107
GO:0051325	interphase	0.0428389829493994
GO:0050828	regulation of liquid surface tension	0.0440488207431105
GO:0042535	positive regulation of tumor necrosis factor biosynthetic process	0.0440488207431105
GO:0007610	behavior	0.0440488207431105
GO:0005085	guanyl-nucleotide exchange factor activity	0.0498283844727028

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

---

Cell Type

Ontology term	p-value	n
classical monocyte	2.57e-124	42
CD14-positive, CD16-negative classical monocyte	2.57e-124	42
defensive cell	2.21e-107	48
phagocyte	2.21e-107	48
monopoietic cell	1.08e-87	59
monocyte	1.08e-87	59
monoblast	1.08e-87	59
promonocyte	1.08e-87	59
macrophage dendritic cell progenitor	1.70e-84	61
myeloid leukocyte	1.16e-81	72
myeloid lineage restricted progenitor cell	2.40e-77	66
granulocyte monocyte progenitor cell	4.84e-76	67
stuff accumulating cell	3.03e-54	87
nongranular leukocyte	1.49e-53	115
myeloid cell	8.80e-51	108
common myeloid progenitor	8.80e-51	108
leukocyte	2.32e-50	136
hematopoietic lineage restricted progenitor cell	7.30e-44	120
hematopoietic stem cell	1.99e-38	168
angioblastic mesenchymal cell	1.99e-38	168
hematopoietic cell	7.61e-36	177
hematopoietic oligopotent progenitor cell	4.03e-35	161
hematopoietic multipotent progenitor cell	4.03e-35	161
intermediate monocyte	1.09e-28	9
CD14-positive, CD16-positive monocyte	1.09e-28	9
mesenchymal cell	9.60e-12	354
connective tissue cell	2.79e-11	361
non-classical monocyte	3.13e-11	3
CD14-low, CD16-positive monocyte	3.13e-11	3
basophil	9.76e-11	3
single nucleate cell	6.60e-10	3
mononuclear cell	6.60e-10	3
motile cell	1.18e-09	386
multi fate stem cell	1.10e-07	427
somatic stem cell	2.04e-07	433
stem cell	4.53e-07	441

Uber Anatomy

Ontology term	p-value	n
hematopoietic system	7.66e-87	98
blood island	7.66e-87	98
hemolymphoid system	1.20e-80	108
bone marrow	7.87e-66	76
immune system	1.27e-62	93
bone element	2.97e-60	82
skeletal element	5.79e-54	90
skeletal system	1.67e-47	100
lateral plate mesoderm	2.05e-35	203
musculoskeletal system	4.11e-24	167
mesoderm	3.63e-19	315
mesoderm-derived structure	3.63e-19	315
presumptive mesoderm	3.63e-19	315
blood	5.57e-18	15
haemolymphatic fluid	5.57e-18	15
organism substance	5.57e-18	15
connective tissue	1.19e-10	371

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
MA0003.1	0.107657
MA0004.1	0.524825
MA0006.1	0.0792944
MA0007.1	0.2248
MA0009.1	0.0785646
MA0014.1	0.00604283
MA0017.1	0.527005
MA0019.1	0.136127
MA0024.1	0.0349195
MA0025.1	0.0438943
MA0027.1	1.14523
MA0028.1	0.0714498
MA0029.1	0.244941
MA0030.1	0.228152
MA0031.1	0.444217
MA0038.1	0.512162
MA0040.1	0.253759
MA0041.1	0.024857
MA0042.1	0.100111
MA0043.1	0.0173155
MA0046.1	0.0729545
MA0048.1	0.236793
MA0050.1	0.101387
MA0051.1	0.231902
MA0052.1	0.12533
MA0055.1	1.18739
MA0056.1	0
MA0057.1	0.540272
MA0058.1	1.03121
MA0059.1	0.844689
MA0060.1	0.00153203
MA0061.1	0.0515203
MA0063.1	0
MA0066.1	3.07373
MA0067.1	0.352304
MA0068.1	0.303382
MA0069.1	0.362561
MA0070.1	0.0656211
MA0071.1	1.34689
MA0072.1	1.18607
MA0073.1	0.236739
MA0074.1	0.141301
MA0076.1	0.0321883
MA0077.1	0.0600262
MA0078.1	0.512474
MA0081.1	2.41667
MA0083.1	0.0183531
MA0084.1	0.207585
MA0087.1	0.0624003
MA0088.1	2.08506
MA0089.1	0
MA0090.1	0.258322
MA0091.1	0.697148
MA0092.1	0.368299
MA0093.1	0.653873
MA0095.1	0
MA0098.1	0
MA0100.1	0.0486853
MA0101.1	0.0580521
MA0103.1	0.268655
MA0105.1	0.428085
MA0106.1	0.907238
MA0107.1	0.0220736
MA0108.2	0.00325094
MA0109.1	0
MA0111.1	0.690246
MA0113.1	0.0815544
MA0114.1	1.00911
MA0115.1	0.268062
MA0116.1	4.1658
MA0117.1	0.0999228
MA0119.1	1.66474
MA0122.1	0.116434
MA0124.1	0.0633695
MA0125.1	0.154028
MA0130.1	0
MA0131.1	0.247819
MA0132.1	0
MA0133.1	0
MA0135.1	0.44952
MA0136.1	2.0668
MA0139.1	0.0322007
MA0140.1	0.36119
MA0141.1	0.53782
MA0142.1	0.555126
MA0143.1	0.15405
MA0144.1	0.0113096
MA0145.1	0.501795
MA0146.1	1.68845
MA0147.1	0.138517
MA0148.1	0.65268
MA0149.1	4.3059
MA0062.2	0.0423768
MA0035.2	0.0915031
MA0039.2	2.4389
MA0138.2	0.72117
MA0002.2	0.324963
MA0137.2	0.00795194
MA0104.2	0.0600514
MA0047.2	0.313123
MA0112.2	2.97413
MA0065.2	2.76392
MA0150.1	0.108782
MA0151.1	0
MA0152.1	0.00269712
MA0153.1	0.0353782
MA0154.1	4.1115
MA0155.1	2.98798
MA0156.1	0.837693
MA0157.1	0.0885999
MA0158.1	0
MA0159.1	1.02096
MA0160.1	0.294889
MA0161.1	0
MA0162.1	4.81311e-06
MA0163.1	1.1909
MA0164.1	0.431322
MA0080.2	7.20307
MA0018.2	0.132752
MA0099.2	0.00932172
MA0079.2	0.00271096
MA0102.2	0.230633
MA0258.1	1.63488
MA0259.1	0.165675
MA0442.1	0

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF	#promoters	Enrichment	p-value	q-value
SPI1#6688	59	2.39631231189525	8.62809779252941e-11	9.43570581522491e-09

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---